Related Experiment Video
Updated: Jul 9, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells
1Molecular Oncology Program, Cutaneous Oncology Division, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Abstract:
The B-Raf(V600E) mutant, found in 65% of human melanomas, drives constitutive activation of the extracellular signal-regulated kinase (ERK) pathway and is implicated in tumorigenesis. Recently, we showed that B-Raf is important for spindle formation and the mitotic spindle checkpoint arrest. In this study, we demonstrate that B-Raf(V600E) signaling deregulates the spindle checkpoint as a consequence of stabilizing monopolar spindle 1 (Mps1) levels in human melanoma cells. Upon introducing the B-Raf(V600E) mutant into wild-type B-Raf melanoma cells, Mps1 protein and activity increased 3- and 10-fold, respectively. In addition, Mps1 became hyperphosphorylated, which correlated with stabilization of Mps1 protein levels. In contrast, reduction of B-Raf by RNAi or inactivation of ERK by the MEK inhibitor U0126 resulted in a precipitous decline in Mps1 levels. Together, these results suggest that B-Raf signaling through ERK regulates the stability of Mps1. Finally, B-Raf(V600E) expression induces a mitotic delay due to promoting robust activation of the mitotic spindle checkpoint. These effects were dependent on the induction of Mps1 levels by oncogenic B-Raf(V600E) as shown by depleting Mps1 with short interfering RNA. Collectively, our findings implicate a new mechanism through which B-Raf(V600E) exerts its oncogenic effects in melanoma.
Insights
The B-Raf(V600E) mutation in melanoma stabilizes Mps1 protein levels, leading to spindle checkpoint activation and mitotic delay. This highlights a new oncogenic mechanism driven by B-Raf signaling.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Cycle Regulation
Background:
- The B-Raf(V600E) mutation is prevalent in human melanomas, driving tumor growth via the ERK pathway.
- B-Raf plays a role in spindle formation and mitotic checkpoint control.
Purpose of the Study:
- To investigate how B-Raf(V600E) signaling affects the spindle checkpoint in melanoma.
- To elucidate the role of Mps1 (monopolar spindle 1) in B-Raf-driven tumorigenesis.
Main Methods:
- Introducing B-Raf(V600E) into wild-type melanoma cells.
- Utilizing RNA interference (RNAi) to reduce B-Raf levels.
- Employing a MEK inhibitor (U0126) to block ERK signaling.
- Measuring Mps1 protein levels and activity.
- Using short interfering RNA (siRNA) to deplete Mps1.
Main Results:
- B-Raf(V600E) increased Mps1 protein and activity, leading to Mps1 hyperphosphorylation and stabilization.
- B-Raf reduction or ERK inhibition decreased Mps1 levels.
- B-Raf(V600E) induced a mitotic delay dependent on elevated Mps1 levels.
Conclusions:
- B-Raf signaling, through ERK, regulates Mps1 stability.
- B-Raf(V600E) promotes melanoma oncogenesis by deregulating the spindle checkpoint via Mps1 stabilization.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Abnormal Proliferation
MAPK Signaling Cascades
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Negative Regulator Molecules